SCHEMBL23854433

SCHEMBL23854433

FC(F)(c1nc2ccccc2[nH]1)C(F)(F)C(F)(F)C(F)(F)c1nc2ccccc2[nH]1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 4/20 0.72
ALDH1A1 P00352 6/20 0.52
POLB P06746 3/20 0.52
KDM4E B2RXH2 5/20 0.50
NPC1 O15118 5/20 0.50
RAB9A P51151 5/20 0.50
PKM P14618 4/20 0.50
HSD17B10 Q99714 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
ABCB11 O95342 1/20 0.50
TP53 P04637 1/20 0.50
KHK P50053 1/20 0.50
IDO1 P14902 1/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
MASP2 O00187 1/20 0.47
NUDT1 P36639 1/20 0.47
AOC3 Q16853 1/20 0.47
MAPT P10636 2/20 0.46
THRB P10828 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29961428 0.93 NPSR1 (0.68) NPSR1ALDH1A1POLBKDM4ENPC1
SCHEMBL28666603 0.93 NPSR1 (0.68) NPSR1ALDH1A1POLBKDM4ENPC1
SCHEMBL4374246 0.92 NPSR1 (0.78) NPSR1ALDH1A1POLBKDM4ENPC1
Bromide SCHEMBL10525679 0.91 NPSR1 (0.66) NPSR1ALDH1A1POLBKDM4ENPC1
SCHEMBL5015526 0.89 NPSR1 (0.72) NPSR1ALDH1A1POLBKDM4ENPC1
SCHEMBL29353981 0.84 NPSR1 (1.00) NPSR1ALDH1A1POLBKDM4ENPC1
SCHEMBL10295 0.84 NPSR1 (1.00) NPSR1ALDH1A1POLBKDM4ENPC1
SCHEMBL9960528 0.82 NPSR1 (0.75) NPSR1ALDH1A1POLBKDM4ENPC1
SCHEMBL7532421 0.81 NPSR1 (0.72) NPSR1ALDH1A1POLBKDM4ENPC1
SCHEMBL13049405 0.81 NPSR1 (0.72) NPSR1ALDH1A1POLBKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11912825-B2 Polymers derived from 2,2′-bisimidazoles THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2024-02-27 US disclosed
US-11912825-B2 Polymers derived from 2,2′-bisimidazoles THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2024-02-27 US disclosed
US-20210301085-A1 POLYMERS DERIVED FROM 2,2'-BISIMIDAZOLES UNITED STATES DEPARTMENT OF ENERGY 2021-09-30 US disclosed
US-20210301085-A1 POLYMERS DERIVED FROM 2,2'-BISIMIDAZOLES UNITED STATES DEPARTMENT OF ENERGY 2021-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210301085-A1 POLYMERS DERIVED FROM 2,2'-BISIMIDAZOLES PARG, PARN, NOP2 NPSR1 4417/4885ALDH1A1 2034/4885POLB 22/4885
US-11912825-B2 Polymers derived from 2,2′-bisimidazoles PARG, PARN, NOP2 NPSR1 4409/4885ALDH1A1 2052/4885POLB 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.